Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164372 · ClinicalTrials.gov registry record · Phase 2
Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,400
- Enrollment target
NCT00164372 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,400 participants.
The verdict
NCT00164372, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.
Interventions
- BEHAVIORAL Peer Education Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2002-05 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164372
The ClinicalTrials.gov registry entry for NCT00164372 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peer Education Intervention is the first listed.
NCT00164372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00164372 about?
NCT00164372 is a clinical study titled "Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users". The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.
What is the current status of trial NCT00164372?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,400 participants. The study started on 2002-05. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00164372?
The interventions under investigation include: Peer Education Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164372?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.